Select the appropriate treatment regimen to improve morbidity and mortality in immunocompromised paediatric patients with invasive candidiasis

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.25, Iss.7, 2009-07, pp. : 10-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Invasive Candidiasis in Immunocompromised Pediatric Patients

By Fisher Brian T.   Zaoutis Theoklis E.  

Pediatric Drugs, Vol. 10, Iss. 5, 2008-01 ,pp. : 281-298

Adis International

Access to resources Recommend Favorite

Current Strategies in the Treatment of Invasive Aspergillus Infections in Immunocompromised Patients

By Harari S.  

Drugs, Vol. 58, Iss. 4, 1999-10 ,pp. : 621-631

Adis International

Access to resources Recommend Favorite

Optimization of voriconazole dosage regimen to improve the efficacy in patients with invasive fungal disease by pharmacokinetic/pharmacodynamic analysis

By  

Fundamental & Clinical Pharmacology, Vol. 30, Iss. 5, 2016-10 ,pp. : 459-465

John Wiley & Sons Inc

Access to resources Recommend Favorite

Resource Utilization and Cost of Treatment with Anidulafungin or Fluconazole for Candidaemia and Other Forms of Invasive Candidiasis: Focus on Critically Ill Patients

By Reboli Annette C.  

PharmacoEconomics, Vol. 29, Iss. 8, 2011-08 ,pp. : 705-717

Adis International

Access to resources Recommend Favorite

Invasive Aspergillosis: Epidemiology, Diagnosis and Management in Immunocompromised Patients

By Maschmeyer Georg  

Drugs, Vol. 67, Iss. 11, 2007-01 ,pp. : 1567-1601

Adis International

Access to resources Recommend Favorite